Crossmark

A novel tumor immunotherapy-related signature for risk stratification, prognosis prediction, and immune status in hepatocellular carcinoma

Published Online: 2023-10-31

Authors

Sun, Jianping

Xi, Lefeng

Zhang, Dechen

Gao, Feipei

Wang, Liqin

Yang, Guangying
License Information

Text and Data Mining valid from 2023-10-31

Version of Record valid from 2023-10-31
More Information

Article History

Received: 13 June 2023

Accepted: 30 October 2023

First Online: 31 October 2023

Competing interests

: The authors declare no competing interests.

Document is current